Activation of erythrocyte aldose reductase in man in response to glycaemic challenge.

Flux via the polyol pathway, which comprises the enzymes aldose reductase (AR) and sorbitol dehydrogenase (SDH), has been implicated in the debilitating complications of diabetes. Previous studies in this laboratory have indicated that erythrocyte AR activities are increased (by 72%) in insulin-dependent diabetic patients. To investigate the mechanism underlying this activation, the response of AR activity to oral glucose challenge was investigated in eight overnight-fasted human volunteers. Glucose consumption led to a transient activation (by 76%: P less than 0.01) of erythrocyte AR, which paralleled the rise and subsequent fall in blood glucose concentrations. It is concluded that erythrocyte AR activity is acutely modulated in response to hyperglycaemia by an as yet unknown mechanism.

[1]  S. Srivastava,et al.  Activated and unactivated forms of human erythrocyte aldose reductase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Steffes,et al.  Effects of Sorbinil on Glomerular Structure and Function in Long-Term–Diabetic Rats , 1989, Diabetes.

[3]  H. Cheng,et al.  The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. , 1986, Metabolism: clinical and experimental.

[4]  P. Campochiaro,et al.  Aldose Reductase Expression in Human Diabetic Retina and Retinal Pigment Epithelium , 1988, Diabetes.

[5]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[6]  A. Cerami,et al.  Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. , 1988, Diabetes/metabolism reviews.

[7]  D. Greene,et al.  Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol. , 1987, The Journal of clinical investigation.

[8]  J. Kinoshita,et al.  Role of aldose reductase in the development of diabetes-associated complications. , 1985, The American journal of medicine.

[9]  Y. Akagi,et al.  Immunohistochemical localization for aldose reductase in diabetic lenses. , 1987, Investigative ophthalmology & visual science.

[10]  D Stribling,et al.  Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. , 1985, Metabolism: clinical and experimental.

[11]  D. Greene,et al.  Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. , 1975, The Journal of clinical investigation.

[12]  L. Chylack,et al.  Direct Measurement of Polyol Pathway Activity in the Ocular Lens , 1984, Diabetes.

[13]  T. Flynn,et al.  Aldose reductase from human psoas muscle. Affinity labeling of an active site lysine by pyridoxal 5'-phosphate and pyridoxal 5'-diphospho-5'-adenosine. , 1989, The Journal of biological chemistry.

[14]  D. Garland,et al.  Bovine lens aldose reductase: identification of two enzyme forms. , 1989, Archives of biochemistry and biophysics.

[15]  W. Whelan,et al.  An improved method for enzymic determination of glucose in the presence of maltose. , 1969, Analytical biochemistry.

[16]  E. Beutler,et al.  The sorbitol-oxidizing enzyme of red blood cells. , 1975, The Journal of laboratory and clinical medicine.